Cargando…
Development of Alveolar Hemorrhage After Pfizer-BioNTech COVID-19 mRNA Vaccination in a Patient With Renal-Limited Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report
Since the coronavirus disease 2019 (COVID-19) pandemic continues and a new variant of the virus has emerged, the COVID-19 vaccination campaign has progressed. Rare but severe adverse outcomes of COVID-19 vaccination such as anaphylaxis and myocarditis have begun to be noticed. Of note, several cases...
Autores principales: | Nishioka, Ken, Yamaguchi, Shintaro, Yasuda, Itaru, Yoshimoto, Norifumi, Kojima, Daiki, Kaneko, Kenji, Aso, Mitsuhiro, Nagasaka, Tomoki, Yoshida, Eriko, Uchiyama, Kiyotaka, Tajima, Takaya, Yoshino, Jun, Yoshida, Tadashi, Kanda, Takeshi, Itoh, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023855/ https://www.ncbi.nlm.nih.gov/pubmed/35462990 http://dx.doi.org/10.3389/fmed.2022.874831 |
Ejemplares similares
-
Antineutrophil cytoplasmic antibody-associated vasculitis predominantly manifesting tubulointerstitial nephritis: A case report
por: Nishioka, Ken, et al.
Publicado: (2023) -
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2021) -
Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022) -
“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech
por: Suzuki, Minami, et al.
Publicado: (2022)